N,N-[2,5-O-[Dibenzyl]-glucaryl]-DI-[isoleucyl-amido-methane]

DB03908ExperimentalSmall molecule

N,N-[2,5-O-[Dibenzyl]-glucaryl]-DI-[isoleucyl-amido-methane]: Overview.

Chemical structure of N,N-[2,5-O-[Dibenzyl]-glucaryl]-DI-[isoleucyl-amido-methane]
Formula / weight
C34H50N4O8 · 642.7828 g/mol (avg)
Also known as
Inhibitor Bea322

Resolves to

Compound
PubChem445303
Structure
InChIKeyGLKONBHDVMFJNJ-XAOMMOPXSA-NSMILES[H]N(C)C(=O)[C@@H](N([H])C(=O)[C@H](OCC1=CC=CC=C1)[C@H](O)[C@@H](O)[C@@H](OCC1=CC=CC=C1)C(=O)N([H])[C@@H]([C@@H](C)CC)C(=O)N([H])C)[C@@H](C)CC
Targets
P03366gag-pol

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with N,N-[2,5-O-[Dibenzyl]-glucaryl]-DI-[isoleucyl-amido-methane], and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In